Last updated on February 2017

A Study of INCB039110 in Combination With Ibrutinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma


Other Details:

For more information, please contact Incyte Corporation at 1.855.463.3463.



Find a site near you

Start Over

Research Center

Located in: Greenville, SC USA
  Connect »